The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability

Metabolism: Clinical and Experimental

Volumn 56, Issue 6, 2007, Pages 723-731

  Helwig, Ulf ^a,b   Rubin, Diana ^a,b   Klapper, Maja ^c   Li, Yin ^a,c   Nothnagel, Michael ^b   Fölsch, Ulrich R ^b   Döring, Frank ^c   Schreiber, Stefan ^b   Schrezenmeir, Jürgen ^a  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 2; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXON; GENOTYPE; HEMOSTASIS; HUMAN; HYPERLIPIDEMIA; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN POLYMORPHISM; PROTEOMICS; TEST MEAL;

AGED; EXONS; FATTY ACID-BINDING PROTEINS; HUMANS; HYPERLIPIDEMIAS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTPRANDIAL PERIOD; PROMOTER REGIONS (GENETICS);

EID: 34248375642     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.11.014     Document Type: Article

References (43)

1. Sweetser D.A., Birkenmeier E.H., Klisak I.J., Zollman S., Sparkes R.S., Mohandas T., et al. The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. J Biol Chem 262 (1987) 16060-16071
2. Sweetser D.A., Heuckeroth R.O., and Gordon J.I. The metabolic significance of mammalian fatty-acid-binding proteins: abundant proteins in search of a function. Annu Rev Nutr 7 (1987) 337-359
3. Lowe J.B., Sacchettini J.C., Laposata M., McQuillan J.J., and Gordon J.I. Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J Biol Chem 262 (1987) 5931-5937
4. Bernlohr D.A., Simpson M.A., Hertzel A.V., and Banaszak L.J. Intracellular lipid-binding proteins and their genes. Annu Rev Nutr 17 (1997) 277-303
5. Agellon L.B., Toth M.J., and Thomson A.B. Intracellular lipid binding proteins of the small intestine. Mol Cell Biochem 239 (2002) 79-82
6. Besnard P., Niot I., Poirier H., Clement L., and Bernard A. New insights into the fatty acid-binding protein (FABP) family in the small intestine. Mol Cell Biochem 239 (2002) 139-147
7. Zimmerman A.W., and Veerkamp J.H. New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci 59 (2002) 1096-1116
8. Hanhoff T., Lucke C., and Spener F. Insights into binding of fatty acids by fatty acid binding proteins. Mol Cell Biochem 239 (2002) 45-54
9. Vassileva G., Huwyler L., Poirier K., Agellon L.B., and Toth M.J. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J 14 (2000) 2040-2046
10. Baier L.J., Sacchettini J.C., Knowler W.C., Eads J., Paolisso G., Tataranni P.A., et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95 (1995) 1281-1287
11. Baier L.J., Bogardus C., and Sacchettini J.C. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 271 (1996) 10892-10896
12. Levy E., Menard D., Delvin E., Stan S., Mitchell G., Lambert M., et al. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem 276 (2001) 39679-39684
13. Sipilainen R., Uusitupa M., Heikkinen S., Rissanen A., and Laakso M. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab 82 (1997) 2629-2632
14. Rissanen J., Pihlajamaki J., Heikkinen S., Kekalainen P., Kuusisto J., and Laakso M. The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects. Diabetes 46 (1997) 711-712
15. Pihlajamaki J., Rissanen J., Heikkinen S., Karjalainen L., and Laakso M. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 17 (1997) 1039-1044
16. Agren J.J., Valve R., Vidgren H., Laakso M., and Uusitupa M. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 18 (1998) 1606-1610
17. Guettier J.M., Georgopoulos A., Tsai M.Y., Radha V., Shanthirani S., Deepa R., et al. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. J Clin Endocrinol Metab 90 (2005) 1705-1711
18. Nakanishi S., Yamane K., Kamei N., Okubo M., and Kohno N. The effect of polymorphism in the intestinal fatty acid-binding protein 2 gene on fat metabolism is associated with gender and obesity amongst non-diabetic Japanese-Americans. Diabetes Obes Metab 6 (2004) 45-49
19. Yamada K., Yuan X., Ishiyama S., Koyama K., Ichikawa F., Koyanagi A., et al. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40 (1997) 706-710
20. Duarte N.L., Colagiuri S., Palu T., Wang X.L., and Wilcken D.E. Obesity, type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population. Mol Genet Metab 79 (2003) 183-188
21. Lara-Castro C., Hunter G.R., Lovejoy J.C., Gower B.A., and Fernandez J.R. Association of the intestinal fatty acid-binding protein Ala54Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women. J Clin Endocrinol Metab 90 (2005) 1196-1201
22. Tahvanainen E., Molin M., Vainio S., Tiret L., Nicaud V., Farinaro E., et al. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis 152 (2000) 317-325
23. Marin C., Perez-Jimenez F., Gomez P., Delgado J., Paniagua J.A., Lozano A., et al. The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am J Clin Nutr 82 (2005) 196-200
24. Geschonke K., Klempt M., Lynch N., Schreiber S., Fenselau S., and Schrezenmeir J. Detection of a promoter polymorphism in the gene of intestinal fatty acid binding protein (I-FABP). Ann NY Acad Sci 967 (2002) 548-553
25. Damcott C.M., Feingold E., Moffett S.P., Barmada M.M., Marshall J.A., Hamman R.F., et al. Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels. Hum Genet 112 (2003) 610-616
26. Formanack M.L., and Baier L.J. Variation in the FABP2 promoter affects gene expression: implications for prior association studies. Diabetologia 47 (2004) 349-351
27. Li Y., Fisher E., Klapper M., Boeing H., Pfeiffer A., Hampe J., et al. Association between functional FABP2 promoter haplotype and type 2 diabetes. Horm Metab Res 38 (2006) 300-307
28. Lahti-Koski M., Pietinen P., Mannisto S., and Vartiainen E. Trends in waist-to-hip ratio and its determinants in adults in Finland from 1987 to 1997. Am J Clin Nutr 72 (2000) 1436-1444
29. WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854 (1995) 1-452
30. ADA. Screening for type 2 diabetes. American Diabetes Association. Diabetes Care 27 (2004) S11-S14
31. Schrezenmeir J., Keppler I., Fenselau S., Weber P., Biesalski H.K., Probst R., et al. The phenomenon of a high triglyceride response to an oral lipid load in healthy subjects and its link to the metabolic syndrome. Ann NY Acad Sci 683 (1993) 302-314
32. Hampe J., Shaw S.H., Saiz R., Leysens N., Lantermann A., Mascheretti S., et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 65 (1999) 1647-1655
33. Schachtrup C., Emmler T., Bleck B., Sandqvist A., and Spener F. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins. Biochem J 382 (2004) 239-245
34. Nitz I., Doring F., Schrezenmeir J., and Burwinkel B. Identification of new acyl-CoA binding protein transcripts in human and mouse. Int J Biochem Cell Biol 37 (2005) 2395-2405
35. Devlin B., and Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29 (1995) 311-322
36. Pratley R.E., Baier L., Pan D.A., Salbe A.D., Storlien L., Ravussin E., et al. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 41 (2000) 2002-2008
37. Weiss E.P., Brown M.D., Shuldiner A.R., and Hagberg J.M. Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects. Physiol Genomics 10 (2002) 145-157
38. Schrezenmeir J., Weber P., Probst R., Biesalski H.K., Luley C., Prellwitz W., et al. Postprandial pattern of triglyceride-rich lipoprotein in normal-weight humans after an oral lipid load: exaggerated triglycerides and altered insulin response in some subjects. Ann Nutr Metab 36 (1992) 186-196
39. Ivy J.L., Zderic T.W., and Fogt D.L. Prevention and treatment of non-insulin-dependent diabetes mellitus. Exerc Sport Sci Rev 27 (1999) 1-35
40. Chiu K.C., Chuang L.M., and Yoon C. The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasian. BMC Genet 2 (2001) 7
41. Chiu K.C., Chuang L.M., Chu A., and Yoon C. Fatty acid binding protein 2 and insulin resistance. Eur J Clin Invest 31 (2001) 521-527
42. Hegele R.A., Harris S.B., Hanley A.J., Sadikian S., Connelly P.W., and Zinman B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 81 (1996) 4334-4337
43. Hayakawa T., Nagai Y., Nohara E., Yamashita H., Takamura T., Abe T., et al. Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects. Metabolism 48 (1999) 655-657